Detalhe da pesquisa
1.
PLK4 as a potential target to enhance radiosensitivity in triple-negative breast cancer.
Radiat Oncol
; 19(1): 24, 2024 Feb 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-38365710
2.
Involvement of the AKT Pathway in Resistance to Erlotinib and Cabozantinib in Triple-Negative Breast Cancer Cell Lines.
Biomedicines
; 11(9)2023 Aug 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-37760847
3.
Preclinical Models of Brain Metastases in Breast Cancer.
Biomedicines
; 10(3)2022 Mar 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-35327469
4.
Radiotherapy and radiosensitization in breast cancer: Molecular targets and clinical applications.
Crit Rev Oncol Hematol
; 169: 103566, 2022 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-34890802
5.
Anticancer effects of radiation therapy combined with Polo-Like Kinase 4 (PLK4) inhibitor CFI-400945 in triple negative breast cancer.
Breast
; 58: 6-9, 2021 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-33866248